RenaSci provides a wide range of innovative in vitro, ex vivo and in vivo CNS techniques used to determine the mode of action, efficacy and side-effect profile of centrally acting drugs. These innovative CNS techniques can be used to assist the biotech and pharmacological industry in developing drugs to treat a range of central nervous system disorders including schizophrenia, attention deficit hyperactivity disorder (ADHD), binge-eating disorder and substance abuse disorder.

Contact us

For more details or information on how we can support your project please complete the contact form.